Patents Assigned to SunWay Biotech Co., Ltd.
-
Patent number: 10143678Abstract: Disclosures of the present invention describe a method of treatment of preventing hyperglycemia complications using at least one pharmaceutical made from a red mold product, wherein the red mold product is a red mold rice or a red mold Dioscorea, and the pharmaceutical is an extract obtained from the red mold product. Particularly, the extract can be Monascin, Ankaflavin, or a combination of Monascin and Ankaflavin. Moreover, a variety of experiment data have proved that the extract indeed exhibits a prevention effect in hyperglycemia complications comprising non-alcoholic liver damage and kidney failure.Type: GrantFiled: July 27, 2018Date of Patent: December 4, 2018Assignee: SUNWAY BIOTECH CO., LTD.Inventors: Tzu-Ming Pan, Chun-Lin Lee, Ya-Wen Hsu
-
Patent number: 9394575Abstract: The present invention relates to a lactobacillus mutant, a nucleotide sequence for lactobacillus mutant, and primers for nucleotide sequence of lactobacillus mutant. The lactobacillus mutant is Lactobacillus paracasei subsp. paracasei NTU 101 having the nucleotide sequence of SEQ ID NO 1, and deposited with Deutsche Sammlung von Mikroorganismen and Zellkulturen GmbH (DSMZ, Germany) on Nov. 18, 2013, wherein the accession number of Lactobacillus paracasei subsp. paracasei NTU 101 is DSM 28047. Moreover, a nucleotide sequence for NTU 101 and the primers for the nucleotide sequence are also proposed for facilitating the person skilled in Lactobacillus filed capable of carrying out the strain identification of the NTU 101 according to the present invention. Moreover, the person skilled in Lactobacillus filed can also rapidly complete the strain identification of the NTU 101 by using DNA molecular marker technology, without culturing any isolated Lactobacillus strain or live Lactobacillus bacteria.Type: GrantFiled: November 24, 2014Date of Patent: July 19, 2016Assignee: SUNWAY BIOTECH CO., LTD.Inventors: Tzu-Ming Pan, Chih-Hui Lin, Tsung-Wei Shih
-
Method for manufacturing composition for lowering blood lipid and elevating high-density lipoprotein
Patent number: 9364457Abstract: The present invention discloses a composition for lowering blood lipid and elevating high-density lipoprotein and a method for manufacturing the same; the composition comprises monascin or ankaflavin, or a combination thereof; the manufacturing method comprises the steps of: treating a Monascus fermented product with acetone for three times; elevating the concentration of the Monascus fermented product by a process of decompress concentration; and extracting the monascin and the ankaflavin from the Monascus fermented product with a silica gel column chromatography, a Sephadex LH-20 column chromatography, the silica gel column chromatography, and a preparative high performance liquid chromatography sequentially.Type: GrantFiled: March 7, 2013Date of Patent: June 14, 2016Assignee: SUNWAY BIOTECH CO., LTD.Inventors: Tzu-Ming Pan, Chun-Lin Lee, Cheng-Lun Wu -
Method for manufacturing composition for lowering blood lipid and elevating high-density lipoprotein
Patent number: 9358221Abstract: The present invention discloses a composition for lowering blood lipid and elevating high-density lipoprotein and a method for manufacturing the same; the composition comprises monascin or ankaflavin, or a combination thereof; the manufacturing method comprises the steps of: treating a Monascus fermented product with acetone for three times; elevating the concentration of the Monascus fermented product by a process of decompress concentration; and extracting the monascin and the ankaflavin from the Monascus fermented product with a silica gel column chromatography, a Sephadex LH-20 column chromatography, the silica gel column chromatography, and a preparative high performance liquid chromatography sequentially.Type: GrantFiled: March 7, 2013Date of Patent: June 7, 2016Assignee: SUNWAY BIOTECH CO., LTD.Inventors: Tzu-Ming Pan, Chun-Lin Lee, Cheng-Lun Wu -
Publication number: 20150190440Abstract: The present invention relates to a blood pressure reducing composition and primers for Monascus purpureus NTU 568, wherein the composition is a red mold dioscorea (RMD) manufacturing by way of inoculating a Monascus purpureus NTU 568 to a dioscorea substrate and then treating the inoculated dioscorea with culturing and drying processes. This composition is able to reduce blood pressure and prevent the vascular wall from pathological deterioration; therefore, the composition can be applied to clinical treatment and health food. Moreover, at least one nucleotide sequence for M. purpureus NTU 568 and the primers for the nucleotide sequence are also provided in the present invention in order to facilitate the person skilled in Monascus purpureus related art capable of accomplishing the strain (mutant) identification of the M. purpureus NTU 568.Type: ApplicationFiled: April 17, 2014Publication date: July 9, 2015Applicant: Sunway Biotech Co., LTDInventors: Tzu-Ming Pan, Cheng-Lun Wu
-
Patent number: 8703456Abstract: The present invention discloses a method for manufacturing red mold dioscorea, and the method comprises the following steps: washing and cutting a fresh dioscorea into pieces with a specific dimension; drying the pieces of the fresh dioscorea for making the dried dioscorea contain a specific water content and a specific sulfur content; adding some water with an appropriate ratio to fresh dioscorea or dried dioscorea; sterilizing the dioscorea; after the dioscorea being cooled down, inoculating the dioscorea with Monascus species; cultivating the dioscorea with an appropriate temperature, an appropriate humidity and an appropriate shacking frequency for an appropriate time period; and drying the cultivated red mold dioscorea with an appropriate water content.Type: GrantFiled: July 25, 2013Date of Patent: April 22, 2014Assignee: Sunway Biotech Co., Ltd.Inventors: Tzu-Ming Pan, Chun-Lin Lee
-
Patent number: 8697424Abstract: The present invention discloses a method for manufacturing red mold dioscorea, and the method comprises the following steps: washing and cutting a fresh dioscorea into pieces with a specific dimension; drying the pieces of the fresh dioscorea for making the dried dioscorea contain a specific water content and a specific sulfur content; adding some water with an appropriate ratio to fresh dioscorea or dried dioscorea; sterilizing the dioscorea; after the dioscorea being cooled down, inoculating the dioscorea with Monascus species; cultivating the dioscorea with an appropriate temperature, an appropriate humidity and an appropriate shacking frequency for an appropriate time period; and drying the cultivated red mold dioscorea with an appropriate water content.Type: GrantFiled: May 7, 2012Date of Patent: April 15, 2014Assignee: Sunway Biotech Co., Ltd.Inventors: Tzu-Ming Pan, Chun-Lin Lee
-
Publication number: 20130309731Abstract: The present invention discloses a method for manufacturing red mold dioscorea, and the method comprises the following steps: washing and cutting a fresh dioscorea into pieces with a specific dimension; drying the pieces of the fresh dioscorea for making the dried dioscorea contain a specific water content and a specific sulfur content; adding some water with an appropriate ratio to fresh dioscorea or dried dioscorea; sterilizing the dioscorea; after the dioscorea being cooled down, inoculating the dioscorea with Monascus species; cultivating the dioscorea with an appropriate temperature, an appropriate humidity and an appropriate shacking frequency for an appropriate time period; and drying the cultivated red mold dioscorea with an appropriate water content.Type: ApplicationFiled: July 25, 2013Publication date: November 21, 2013Applicant: SunWay Biotech Co., Ltd.Inventors: Tzu-Ming Pan, Chun-Lin Lee
-
Publication number: 20130189299Abstract: The present invention discloses a composition for lowering blood lipid and elevating high-density lipoprotein and a method for manufacturing the same; the composition comprises monascin or ankaflavin, or a combination thereof; the manufacturing method comprises the steps of: treating a Monascus fermented product with acetone for three times; elevating the concentration of the Monascus fermented product by a process of decompress concentration; and extracting the monascin and the ankaflavin from the Monascus fermented product with a silica gel column chromatography, a Sephadex LH-20 column chromatography, the silica gel column chromatography, and a preparative high performance liquid chromatography sequentially.Type: ApplicationFiled: March 7, 2013Publication date: July 25, 2013Applicant: SUNWAY BIOTECH CO., LTD.Inventor: Sunway Biotech Co., Ltd.
-
Publication number: 20130184473Abstract: The present invention discloses a composition for lowering blood lipid and elevating high-density lipoprotein and a method for manufacturing the same; the composition comprises monascin or ankaflavin, or a combination thereof; the manufacturing method comprises the steps of: treating a Monascus fermented product with acetone for three times; elevating the concentration of the Monascus fermented product by a process of decompress concentration; and extracting the monascin and the ankaflavin from the Monascus fermented product with a silica gel column chromatography, a Sephadex LH-20 column chromatography, the silica gel column chromatography, and a preparative high performance liquid chromatography sequentially.Type: ApplicationFiled: March 7, 2013Publication date: July 18, 2013Applicant: SUNWAY BIOTECH CO., LTD.Inventor: SUNWAY BIOTECH CO., LTD.
-
Publication number: 20130089641Abstract: The present invention relates to a soymilk with additive of vitamin C, vitamin C salts or vitamin C stereoisomer, wherein the soymilk with vitamin C additive is made by adding an ascorbic acid into a drink fabricated by using at least one kind of bean as the raw material, and the soymilk with vitamin C additive is helpful to increase the iron absorptivity in small intestine, the additive dosage of the ascorbic acid is ranged from 25 mg/100 ml to 50 mg/100 ml. Moreover, the equivalent dosage of the ascorbate ion provided by the ascorbate or ascorbic acid stereoisomer is also ranged from 25 mg/100 ml to 50 mg/100 ml.Type: ApplicationFiled: October 11, 2011Publication date: April 11, 2013Applicant: SUNWAY BIOTECH CO., LTD.Inventors: Tzu-Ming PAN, Cheng-Lun WU
-
Publication number: 20130012576Abstract: The present invention discloses a composition for lowering blood lipid and elevating high-density lipoprotein and a method for manufacturing the same; the composition comprises monascin or ankaflavin, or a combination thereof; the manufacturing method comprises the steps of: treating a Monascus fermented product with acetone for three times; elevating the concentration of the Monascus fermented product by a process of decompress concentration; and extracting the monascin and the ankaflavin from the Monascus fermented product with a silica gel column chromatography, a Sephadex LH-20 column chromatography, the silica gel column chromatography, and a preparative high performance liquid chromatography sequentially.Type: ApplicationFiled: August 23, 2011Publication date: January 10, 2013Applicant: SUNWAY BIOTECH CO., LTD.Inventors: Tzu-Ming PAN, Chun-Lin LEE, Chen-Lun WU
-
Publication number: 20120220017Abstract: The present invention discloses a method for manufacturing red mold dioscorea, and the method comprises the following steps: washing and cutting a fresh dioscorea into pieces with a specific dimension; drying the pieces of the fresh dioscorea for making the dried dioscorea contain a specific water content and a specific sulfur content; adding some water with an appropriate ratio to fresh dioscorea or dried dioscorea; sterilizing the dioscorea; after the dioscorea being cooled down, inoculating the dioscorea with Monascus species; cultivating the dioscorea with an appropriate temperature, an appropriate humidity and an appropriate shacking frequency for an appropriate time period; and drying the cultivated red mold dioscorea with an appropriate water content.Type: ApplicationFiled: May 7, 2012Publication date: August 30, 2012Applicant: SUNWAY BIOTECH CO., LTD.Inventors: Tzu-Ming PAN, Chun-Lin LEE
-
Patent number: 8097259Abstract: This invention provides method for the treatment and prevention of Alzheimer's disease without noticeable side effects caused to patients, comprising administering an effective amount of Monascus-fermented product including Monascus powder and Monascus beverage. The Monascus powder and beverage are prepared through specific fermentation procedures disclosed and comprise monacolins, anti-inflammation agents and anti-oxidant compounds. The Monascus compositions are extracted from fermented red mold rice (RMR).Type: GrantFiled: March 15, 2010Date of Patent: January 17, 2012Assignee: SunWay Biotech Co., Ltd.Inventors: Tzu-Ming Pan, Chun-Lin Lee
-
Publication number: 20100278983Abstract: The present invention discloses a composition of Monascus fermented product with a function that reduces body fatness formation and the method for manufacturing the same, the substrates for manufacturing Monascus fermented product are rice and dioscorea, and the manufacturing method is to use water and ethanol to be solutions in order to manufacture the Monascus fermented product, which is proven to have the effect of reducing body fatness formation by in vitro experiments and animal experiments.Type: ApplicationFiled: January 20, 2010Publication date: November 4, 2010Applicant: SUNWAY BIOTECH CO., LTD.Inventors: Tzu-Ming PAN, Wen-Pei CHEN
-
Publication number: 20100273241Abstract: The present invention discloses a method for manufacturing red mold dioscorea, and the method comprises the following steps: adding some water with an appropriate ratio to fresh dioscorea or dried dioscorea; sterilizing the dioscorea; after the dioscorea being cooled down, inoculating the dioscorea with Monascus species; cultivating the dioscorea with an appropriate temperature, an appropriate humidity and an appropriate shacking frequency for an appropriate time period; and drying the cultivated red mold dioscorea with an appropriate water content.Type: ApplicationFiled: January 20, 2010Publication date: October 28, 2010Applicant: SUNWAY BIOTECH CO., LTD.Inventors: Tzu-Ming Pan, Chun-Lin Lee
-
Publication number: 20090053186Abstract: The present invention relates to compositions and methods for ablating tumor cells in a subject having at least one tumor site. More specifically, the method comprises contacting the tumor cells in at least one tumor with a lytic agent in vivo, under lytic conditions, forming a treated tumor; and applying a sufficient in vivo stimulus to the treated tumor forming a stimulated tumor. Compositions and methods are included for shrinking a local tumor or a distal metastatic tumor, or both in a subject. In a preferred embodiment, the method for shrinking a tumor in a subject comprises: contacting a stimulated tumor cells in vivo with a lytic agent. The stimulus directed toward the tumor cells is capable of increasing the level of chaperone proteins in the tumor cells. The combination of lytic agents and tumor cell stimulus leads to shrinkage of the tumors that were treated directly, wherein the stimulus is either applied simultaneously or sequentially.Type: ApplicationFiled: April 29, 2008Publication date: February 26, 2009Applicant: Shanghai Sunway Biotech Co., Ltd.Inventors: Fang Hu, Bo Wu
-
Publication number: 20040202663Abstract: The present invention relates to compositions and methods for ablating tumor cells in a subject having at least one tumor site. More specifically, the method comprises contacting the tumor cells in at least one tumor with a lytic agent in vivo, under lytic conditions, forming a treated tumor; and applying a sufficient in vivo stimulus to the treated tumor forming a stimulated tumor. Compositions and methods are included for shrinking a local tumor or a distal metastatic tumor, or both in a subject. In a preferred embodiment, the method for shrinking a tumor in a subject comprises: contacting a stimulated tumor cells in vivo with a lytic agent. The stimulus directed toward the tumor cells is capable of increasing the level of chaperone proteins in the tumor cells. The combination of lytic agents and tumor cell stimulus leads to shrinkage of the tumors that were treated directly, wherein the stimulus is either applied simultaneously or sequentially.Type: ApplicationFiled: January 28, 2004Publication date: October 14, 2004Applicant: Shanghai Sunway Biotech Co., Ltd.Inventors: Fang Hu, Bo Wu